The size of China's medical device market reaches 445 billion: 'cake' | large, '佼佼者' |

According to the “Development Status of China's Medical Device Industry”, the total size of the medical device market in China was approximately 445 billion yuan in 2017, which is 370 billion yuan more than in 2016, according to the medical network April 27. The local medical device industry is a 'big cake'. The yuan has increased by 75 billion yuan, with a growth rate of approximately 20.27%. However, although the 'cake' is large, the 'defective' is scarce. In addition to the annual revenue of the listed Mindray Medical Co. Enterprises are far from this point. There are industry sources, the industry threshold is high, the degree of concentration is low, facing the pressure of foreign-funded enterprises is a challenge facing domestic medical device companies. But with the classification of treatment and other policies The gradual advancement, the future market potential is still considerable.

At the 78th China International Medical Devices (Spring) Expo and the 26th China International Medical Device Design and Manufacturing Technology (Spring) Exhibition, many domestic medical device companies and foreign-funded enterprises brought their latest products to the show. Want to seize more market share.

'Compared with foreign countries, domestic medical device companies still have huge room for growth. Whether it is R&D, innovation, product quality, or the scale of enterprise development, we have a gap with foreign medical device companies. The world’s top 20 medical devices None of the companies are Chinese companies. This is not in line with our status as a big country. 'The chairman of Lanfan Medical, Liu Wenjing said in an interview with the "Daily Economic News" at the first China Health Protection and Health Summit.

According to the “Development Status of China's Medical Device Industry”, the total size of China's medical device market was approximately 445 billion yuan in 2017, an increase of 75 billion yuan from 370 billion yuan in 2016, with a growth rate of approximately 20.27%. The device is about 320 billion yuan, of which imaging equipment accounted for 19%, in vitro diagnostics accounted for 16%, high-value consumables accounted for 13%.

At present, there are about 16,000 medical device manufacturers in China, and the number of listed companies is about 45. From the perspective of operating income, the current “leading brother” in the field of medical devices is applying now. Entrepreneurship According to the submitted materials, Mindray Medical achieved revenue of RMB 8.013 billion, RMB 9.003 billion and RMB 111.73 billion respectively in 2015, 2016 and 2017. The net profit realized was RMB 940 million and RMB 161 million, respectively. 26.01 billion yuan.

After Mindray Medical, the larger revenues of listed A-list medical device companies include Xinhua Medical, Diving Healthcare and Lepu Medical. Among them, Xinhua Medical (unpublished annual report as of press time) is currently the most likely to be the second The revenue of the company exceeded 10 billion. Xinhua Medical's revenue for the first three quarters of 2017 was 7.09 billion yuan, an increase of 20.09% year-on-year, and a net profit of 12.45 million yuan. It is worth noting that Xinhua Medical's non-compliance in the first three quarters of 2017 The net profit was a loss of 80.99 million yuan. Previously, it had also encountered investment in Chengdu Yingde's 'thunder thunder'. From the perspective of this year's annual results, Xinhua Medical's net profit after deduction is not satisfactory, according to the performance report, Xinhua. According to medical estimates, after deducting net profit attributable to shareholders of listed companies in 2017 compared to the loss of 47,799,000 yuan in the same period of last year, it will reduce by 52.96 million yuan to 76.3 million yuan.

After Xinhua Medical, the top-ranking companies in medical device listed companies were Yu Yue Medical and Lepu Medical. From the revenue point of view, Yu Yue Medical’s operating revenue in 2017 was RMB 3.542 billion, with a net profit of RMB 592 million; In 2017, the operating revenue was 4.538 billion yuan, and the net profit was 899 million yuan, which showed a significant increase year-on-year.

However, it can also be seen that they still have a considerable distance from the 10 billion yuan mark.

Liu Wenjing believes that from medical devices and drug In terms of the scale of the industry, China is 1:4.5, while the United States is 1: 1. Currently, the largest sales revenue of medical equipment companies in China is not as good as a foreign investment in R&D.

However, looking at the entire sector, several industry sources pointed out to the reporter of the “Daily Economic News” that at the mid-end, low-end consumables, domestic companies have achieved good results, even occupying certain segments. A considerable market share, but in high-end equipment is still difficult to truly equal dialogue with foreign-funded enterprises.

Taking Lanfan Medical, which previously focused on health protective gloves, as an example, Lanfan Medical started from the low-end consumables. Its chairman Liu Wenjing told the reporter of “Daily Economic News” that Lanfan Medical has been in the field of global medical protective gloves. Occupy more than 20% of the market share.

After occupying a large share in the low-end consumables field, Lanfan Medical recently completed the acquisition of the controlling stake in Singapore Parkson International, while Singapore Parkson International is mainly engaged in the research, development, production and sales of interventional cardiac surgery instruments. Singapore Parkson International in the cardiovascular stent Ranked fourth in the world, second only to Abbott, Poco and Medtronic. Relying on these two industrial platforms, she stated that the development idea of ​​Lanfan Medical is to build an industrial structure of 'low-value consumables + high-value consumables'. The linear growth of value consumables is predictable. It can withstand potential risks such as R&D cycles and policy impacts of high-value consumables, and can continue to progress through the internationalization platform of high-value consumables, that is, it continues to plunge into the international market while sinking further. Seize domestic demand.

In the field of ultrasound, it is understood that at present, in some big hospitals in the top three, due to policies and other factors, the number of domestically produced ultrasound products and foreign-funded products can be basically evenly divided. However, due to large differences in unit prices, both parties still have sales amounts. It is not a small difference. In the domestic distribution, Mindray Medical was established and several medical companies were opened for major competition.

In terms of exports, the total value of China's medical device exports in 2017 was 21.703 billion U.S. dollars, an increase of 6.84% compared to 2016, and the top 10 countries in total export volume were in Europe and the United States. medicine Deputy Secretary-General of Material Association, medical instruments Branch Secretary-General Chen Hongyan told the reporter of “Daily Economic News” that overall, the status quo of China's medical equipment exports is weak in the high-end, and the low-end and middle-end companies have a certain position in the world. The medical equipment products for export use low-value consumables. End products, massage health care equipment, medical supplies mainly dressings.

Some industry insiders told the reporter of “Daily Economic News” that the establishment of graded medical treatment for primary medical care and the liberalization of social medical services will promote the growth of the domestic medical device market, especially the demand for medium and low-end equipment.

Chen Hongyan believes that the current domestic medical device homogenization competition is serious and urgently requires scientific and technological innovation. It requires innovative thinking and investment in real money and talents, which is partly due to domestic medical devices. enterprise Prior to this, it has been focused on fighting the market. As Liu Wenjing said, courage and dreams alone are not enough.